HOPE-BP 2.0: Evaluating the Optimal Duration of Postpartum Remote Blood Pressure Monitoring

NANot yet recruitingINTERVENTIONAL
Enrollment

400

Participants

Timeline

Start Date

December 1, 2025

Primary Completion Date

January 31, 2028

Study Completion Date

January 31, 2028

Conditions
PostpartumHypertensionHypertensive Disorder of Pregnancy
Interventions
DIAGNOSTIC_TEST

2-Week Home Monitoring

Those who are randomized into the 2-week intervention arm will be unenrolled from the postpartum remote blood pressure monitoring program and therefore will no longer be transmitting twice daily blood pressures for review.

DIAGNOSTIC_TEST

6-Week Home Monitoring

HOPE-BP provides remote monitoring for the 35% of approximately 2,800 annual births at our institution complicated by HDP. Eligible patients enroll at hospital discharge into a 6-week program, submitting blood pressure readings twice daily via Epic's MyChart Care Companion. Participants receive immediate automated feedback, and a dedicated Maternal Fetal Medicine nursing team reviews data daily (Monday-Friday, 8 AM-4 PM), initiating or adjusting antihypertensive therapy as needed.

Trial Locations (1)

55455

University of Minnesota, Minneapolis

All Listed Sponsors
lead

University of Minnesota

OTHER

NCT07204756 - HOPE-BP 2.0: Evaluating the Optimal Duration of Postpartum Remote Blood Pressure Monitoring | Biotech Hunter | Biotech Hunter